Despite limited specificity of natriuretic peptide assessment, their combined assessment with other biomarkers, including those of liver (bilirubin, GGT, AST/ALT) and renal dysfunction (creatinine, eGFR, cystatin C) can signal organ congestion secondary to RV impairment. This evidence concerns the gene CST4 and Abnormal renal physiology.